Ciprofloxacin breakpoints in enteric fever - Time to revise our susceptibility criteria [3]

Indian Journal of Medical Microbiology

Volumn 26, Issue 1, 2008, Pages 91-

  Rodrigues, C ^a   Kumar, N ^a   Lalwani, J ^a   Mehta, A ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID;

ABSENTEEISM; ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; BACTERIUM ISOLATE; BLOOD CULTURE; DISEASE PREDISPOSITION; HUMAN; INFECTION SENSITIVITY; LETTER; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; SALMONELLA PARATYPHI; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 38849090038     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.38874     Document Type: Letter

References (2)

1. Rodrigues C, Mehta A, Joshi VR. Salmonella typhi in the past decade: Learning to live with the resistance. Clin Infect Dis 2002;34:126.
2. Rodrigues C, Mehta A, Shenai S. Enteric fever in Mumbai, India: The good news and the bad news. Clin Infect Dis 2003;36:535.